Physical function during treatment for early-stage gastroesophageal cancer
Part of Cancer, Digestive system clinical trials.
This study looks at how well adults with early-stage cancer of the esophagus, stomach, or the area where they meet can do daily activities while receiving chemotherapy or other systemic therapy. It aims to understand how treatment affects physical function, which may help improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been newly diagnosed with stage I, II, or III cancer of the esophagus, stomach, or the gastroesophageal junction.
- You are planning to start systemic therapy (like chemotherapy) as part of your treatment, and your cancer is considered removable or potentially removable.
- You are able to understand and sign a consent form.
- You do not have cancer that has spread to other parts of the body (metastatic).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an individually designed, supervised exercise program that you do from home to help you regain strength and function after cancer treatment. It is for survivors of early-stage gastroesophageal cancer who are still experiencing physical limitations.
This trial tests a shorter course of radiation combined with chemotherapy (FOLFOX) before surgery for esophageal or stomach-junction cancer. It aims to reduce side effects and still improve outcomes.
This trial compares two chemotherapy combinations, with or without an immunotherapy drug called nivolumab, for people with advanced stomach, esophagus, or gastroesophageal junction cancer that cannot be removed by surgery. The goal is to see which treatment works better and if adding immunotherapy helps.
This Phase 1 trial tests how well a tailored (response-adapted) chemotherapy plan works before surgery for stomach or gastroesophageal junction cancer. It aims to improve treatment planning while checking early safety.
This study tests whether an exercise and nutrition program can improve quality of life for people with incurable esophageal or stomach cancer. It is designed to help you feel better and stay active during treatment.
This trial looks at how your nutrition status affects the success of immunotherapy drugs in people with advanced esophageal squamous cell cancer or stomach adenocarcinoma that has spread. It aims to find if better nutrition leads to better treatment results.
Hear when a new Clinical Stage I Esophageal Adenocarcinoma AJCC v8 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.